BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21671773)

  • 1. After inclusion, information and inference: reporting on clinical trials results after 15 years of monitoring inclusion of women.
    Foulkes MA
    J Womens Health (Larchmt); 2011 Jun; 20(6):829-36. PubMed ID: 21671773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.
    Rochon PA; Clark JP; Binns MA; Patel V; Gurwitz JH
    CMAJ; 1998 Aug; 159(4):321-7. PubMed ID: 9732709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of analysis by gender in the Cochrane reviews as related to treatment of cardiovascular disease.
    Johnson SM; Karvonen CA; Phelps CL; Nader S; Sanborn BM
    J Womens Health (Larchmt); 2003 Jun; 12(5):449-57. PubMed ID: 12869292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.
    Harris DJ; Douglas PS
    N Engl J Med; 2000 Aug; 343(7):475-80. PubMed ID: 10944565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women subjects in NIH-funded clinical research literature: lack of progress in both representation and analysis by sex.
    Vidaver RM; Lafleur B; Tong C; Bradshaw R; Marts SA
    J Womens Health Gend Based Med; 2000 Jun; 9(5):495-504. PubMed ID: 10883941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of women in clinical trials of drug therapies: a context for the controversies.
    Prout MN; Fish SS
    Medscape Womens Health; 2001 Oct; 6(5):1. PubMed ID: 11698923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Working Together to Address Women's Health in Research and Drug Development: Summary of the 2017 Women's Health Congress Preconference Symposium.
    Feuerstein IM; Jenkins MR; Kornstein SG; Lauer MS; Scott PE; Raju TNK; Johnson T; Devaney S; Lolic M; Henderson M; Clayton JA
    J Womens Health (Larchmt); 2018 Oct; 27(10):1195-1203. PubMed ID: 30325292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials.
    Geller SE; Adams MG; Carnes M
    J Womens Health (Larchmt); 2006 Dec; 15(10):1123-31. PubMed ID: 17199453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Representation of women in randomized clinical trials of cardiovascular disease prevention.
    Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's mental health research: the emergence of a biomedical field.
    Blehar MC
    Annu Rev Clin Psychol; 2006; 2():135-60. PubMed ID: 17716067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender bias in clinical trials: do double standards still apply?
    Ramasubbu K; Gurm H; Litaker D
    J Womens Health Gend Based Med; 2001 Oct; 10(8):757-64. PubMed ID: 11703888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women abound in NIH trials.
    Holden C
    Science; 2008 Oct; 322(5899):219. PubMed ID: 18845746
    [No Abstract]   [Full Text] [Related]  

  • 13. Participation of women in clinical trials for new drugs approved by the food and drug administration in 2000-2002.
    Yang Y; Carlin AS; Faustino PJ; Motta MI; Hamad ML; He R; Watanuki Y; Pinnow EE; Khan MA
    J Womens Health (Larchmt); 2009 Mar; 18(3):303-10. PubMed ID: 19243271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicines.
    Sullivan PS; McNaghten AD; Begley E; Hutchinson A; Cargill VA
    J Natl Med Assoc; 2007 Mar; 99(3):242-50. PubMed ID: 17393948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. There is no women's health crisis.
    Satel SL
    Public Interest; 1998; 130():21-33. PubMed ID: 11658109
    [No Abstract]   [Full Text] [Related]  

  • 16. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?
    Geller SE; Koch A; Pellettieri B; Carnes M
    J Womens Health (Larchmt); 2011 Mar; 20(3):315-20. PubMed ID: 21351877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scholarly productivity and national institutes of health funding of foundation for anesthesia education and research grant recipients: insights from a bibliometric analysis.
    Pagel PS; Hudetz JA
    Anesthesiology; 2015 Sep; 123(3):683-91. PubMed ID: 26114414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disfranchisement of fertile women in clinical trials: the legal ramifications of and solutions for rectifying the knowledge gap.
    Bowles LE
    Vanderbilt Law Rev; 1992 May; 45(4):877-920. PubMed ID: 16047448
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing participation of women in early phase clinical trials approved by the FDA.
    Pinnow E; Sharma P; Parekh A; Gevorkian N; Uhl K
    Womens Health Issues; 2009; 19(2):89-93. PubMed ID: 19272558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender(ed) science: How the institutionalization of gender continues to shape the conduct and content of women's health research.
    Philbin MM; Everett BG; Auerbach JD
    Soc Sci Med; 2024 Jun; 351 Suppl 1():116456. PubMed ID: 38825378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.